HMMJ:CA:TSX-Global X Marijuana Life Sciences Index ETF (CAD)

ETF | Sector Equity |

Last Closing

CAD 10.28

Change

+0.09 (+0.88)%

Market Cap

CAD 0.08B

Volume

0.02M

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

NA

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-09-30 )

Largest Industry Peers for Sector Equity

Symbol Name Price(Change) Market Cap
TEC:CA TD Global Technology Leaders I..

+0.14 (+0.35%)

CAD 2.88B
TEC:CA TD Global Technology Leaders I..

+0.14 (+0.35%)

CAD 2.88B
ZWU:CA BMO Covered Call Utilities ETF

N/A

CAD 1.94B
ZWU:CA BMO Covered Call Utilities ETF

N/A

CAD 1.94B
XHC:CA iShares Global Healthcare (CAD..

+0.21 (+0.28%)

CAD 0.65B
XHC:CA iShares Global Healthcare (CAD..

+0.21 (+0.28%)

CAD 0.65B
XIT:CA iShares S&P/TSX Capped Informa..

+0.49 (+0.85%)

CAD 0.65B
XIT:CA iShares S&P/TSX Capped Informa..

+0.49 (+0.85%)

CAD 0.65B
TXF:CA First Asset Tech Giants Covere..

N/A

CAD 0.65B
TXF:CA First Asset Tech Giants Covere..

N/A

CAD 0.65B

ETFs Containing HMMJ:CA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Sector Equity) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 10.66% 50% F 47% F
Dividend Return 2.90% 67% D+ 62% D
Total Return 13.55% 54% F 52% F
Trailing 12 Months  
Capital Gain 13.47% 21% F 40% F
Dividend Return 2.97% 66% D+ 50% F
Total Return 16.43% 33% F 42% F
Trailing 5 Years  
Capital Gain -56.07% 4% F 8% B-
Dividend Return 8.14% 57% F 30% F
Total Return -47.93% 4% F 9% A-
Average Annual (5 Year Horizon)  
Capital Gain -2.47% N/A N/A 22% F
Dividend Return -0.16% N/A N/A 25% F
Total Return 2.31% N/A N/A 61% D-
Risk Return Profile  
Volatility (Standard Deviation) 40.77% N/A N/A 22% F
Risk Adjusted Return -0.39% N/A N/A 26% F
Market Capitalization 0.08B 49% F 31% F

Annual Financials (CAD)

Quarterly Financials (CAD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Low market capitalization

This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.